Walnut Street Julia A. Haller, MD Suite 1510 Philadelphia, PA 19107 Ophthalmologist-in-Chief and William Tasman, MD, Endowed Chair Professor and Chair of Ophthalmology Sidney Kimmel Medical College at Thomas Jefferson Un

Chief Executive Officer

Outlook Therapeutics, Inc.

It has been a real honor and pleasure to serve on the Board

of Directors of Outlook Therapeutics for the last few years.

As you are aware, I have taken on new responsibilities

as CEO here at Wills Eye Hospital. As a result, time constraints are forcing me to limit my outside commitments.

To this end, and with regret and respect, I

will need to step down from the Outlook Therapeutics board effective March 10, 2026.

I am so appreciative of the opportunity over the last years

to work with you and the tremendous team at Outlook to bring new therapies to patients with unmet needs.

I wish the company the very best of luck. You can count on

my continued support.

With warmest regards,